Parameter | Â |
---|---|
Number of patients | 295 |
Admission parameters | |
 Age (years), median (IQR) | 63 (51–72) |
 Females, n (%) | 94 (32 %) |
 SAPS II, median (IQR) | 62 (45–79) |
 SOFA, median (IQR) | 11 (8–15) |
 Heart rate (bpm), median (IQR) | 81 (65–104) |
 MAP (mmHg), median (IQR) | 68 (57–82) |
 Respiratory rate (breaths/min), median (IQR) | 20 (16–25) |
 Body temperature (°C), median (IQR) | 36.5 (35.5–37.5) |
 pH, median (IQR) | 7.30 (7.20–7.40) |
 AST (IU/l), median (IQR) | 366 (73–1265) |
 ALT (IU/l), median (IQR) | 139 (39–706) |
 LDH (IU/l), median (IQR) | 599 (360–1523) |
 INR, median (IQR) | 1.4 (1.2–1.9) |
Peak values | |
 AST (IU/l), median (IQR) | 2457 (1168–5605) |
 ALT (IU/l), median (IQR) | 1151 (534–2620) |
 LDH (IU/l), median (IQR) | 2439 (1334–4999) |
 INR, median (IQR) | 1.8 (1.4–2.7) |
Underlying condition | |
 Cardiogenic shock, n (%) | 130 (44 %) |
 Septic shock, n (%) | 106 (36 %) |
 Mixed septic/cardiogenic shock, n (%) | 3 (1 %) |
 Hemorrhagic shock, n (%) | 8 (3 %) |
Therapy | |
 Mechanical ventilation, n (%) | 225 (76 %) |
 Vasopressor therapy, n (%) | 231 (86 %) |
 Renal replacement therapy, n (%) | 122 (41 %) |
Outcome parameters | |
 28-day mortality, n (%) | 170 (58 %) |
 ICU-LOS (days), median (IQR) | 7 (2–14) |